EXECUTIVE ENGAGEMENTS
OUTREACH
2183
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
393
Interactions with Platform & by Email
PARTICIPANTS
66
Unique # Participated
VALIDATIONS
22
Responses Validated*
COMPETITORS
47
Responses Validated*
* Login for a full stack data experience
DATE
APR 2021
TABLES
108
PAGES
185
EDITION
19
PRICE
USD 5600
*Engagement stats are ongoing and dynamic
HIGHLIGHTS
Amid the COVID-19 crisis, the global market for Mesenchymal Stem Cells (MSC) estimated at US$172.9 Million in the year 2020, is projected to reach a revised size of US$229 Million by 2027, growing at a CAGR of 4.1% over the analysis period 2020-2027. Human MSC, one of the segments analyzed in the report, is projected to record a 4.6% CAGR and reach US$94.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Mouse MSC segment is readjusted to a revised 4% CAGR for the next 7-year period.
The Mesenchymal Stem Cells (MSC) market in the U.S. is estimated at US$50.9 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$40.6 Million by the year 2027 trailing a CAGR of 3.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.8% and 3.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.
In the global Rat MSC segment, USA, Canada, Japan, China and Europe will drive the 3.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$27.7 Million in the year 2020 will reach a projected size of US$36.2 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$25.5 Million by the year 2027.
SELECT PLAYERS
Cell Applications Inc.; Celprogen Inc.; Cyagen US Inc.; Genlantis Inc.; Lonza Group; Mesoblast Limited; MilliporeSigma; Neuromics; Orthofix International N.V.; PromoCell GmbH; R&D Systems Inc.; ScienCell Research Laboratories; Stemcell Technologies Inc.; Stemedica Cell Technologies Inc.; Thermo Fischer Scientific Inc.
SEGMENTS
» Type (Human MSC, Mouse MSC, Rat MSC, Other Types) » Application (Research Institutes, Hospitals, Other Applications)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Mesenchymal Stem Cells Market on a Rapid Growth Path |
| Recent Market Activity |
| Current and Future Analysis |
| The Present and Future of MSC Therapies |
| Select MSC-based Therapeutics |
| Mesenchymal Stem Cell Research |
| Completed Phase III Studies with MSCs |
| MSCs are Being Explored for Several New Treatment Possibilities |
| Widespread Commercialization of 'Off-the-Shelf' MSCs to Become a Reality |
| Software Companies Endeavour to Cash in on the Boom |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| Cell Applications, Inc. (USA) |
| Celprogen, Inc. (USA) |
| Cyagen US Inc. (USA) |
| Genlantis, Inc. (USA) |
| Lonza Group (Switzerland) |
| Mesoblast Limited (Australia) |
| MilliporeSigma (USA) |
| Neuromics (USA) |
| Orthofix International N.V. (Italy) |
| PromoCell GmbH (Germany) |
| R&D Systems, Inc. (USA) |
| ScienCell Research Laboratories (USA) |
| Stemcell Technologies Inc. (Canada) |
| Stemedica Cell Technologies, Inc. (USA) |
| Thermo Fischer Scientific, Inc. (USA) |
| Vitro Biopharma (USA) |
| 3. MARKET TRENDS & DRIVERS |
| Development of Regenerative Medicine Accelerates Demand for MSCs |
| Ageing Demographics to Drive Demand for Mesenchymal Stem Cell Therapies |
| Global Aging Population Statistics - Opportunity Indicators |
| Growing Prevalence of Chronic Diseases Propels Demand for Mesenchymal Stem Cells |
| Key Disease Statistics - Opportunity Indicators |
| Growing Volume of Orthopedic Procedures: An Opportunity for the MSC Market |
| Adult Stem Cell Therapies on Growth Trajectory, as Controversies Continue to Haunt Embryonic Stem Cell Research |
| Adult Stem Cells and Embryonic Stem Cells - A Comparison |
| MSCs Versus Embryonic or Induced Pluripotent Stem Cells |
| MSC Therapies - Immune to Ethical Issues Applicable to Embryonic Stem Cells |
| MSCs - A Potential Vehicle for 'Targeted Drug Delivery' |
| Stem Cell Based Bone Grafts: Promising Growth Ahead |
| Loopholes Associated with In Vivo Properties Constrain Therapeutic Advancements |
| Major Challenges Confronting Mesenchymal Stem Cell Market |
| Allogeneic MSCs - Offering Promise in Immunosuppressive and Tissue Repair Therapy |
| Administration Route Determines the Effectiveness of MSCs |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Mesenchymal Stem Cells (MSC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Human MSC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Human MSC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Human MSC by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Mouse MSC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Mouse MSC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Mouse MSC by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Rat MSC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Rat MSC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Rat MSC by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Type - Percentage Breakdown of Value Sales for Human MSC, Mouse MSC, Rat MSC and Other Types for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Application - Percentage Breakdown of Value Sales for Research Institutes, Hospitals and Other Applications for the Years 2012, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Type - Percentage Breakdown of Value Sales for Human MSC, Mouse MSC, Rat MSC and Other Types for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Application - Percentage Breakdown of Value Sales for Research Institutes, Hospitals and Other Applications for the Years 2012, 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Type - Percentage Breakdown of Value Sales for Human MSC, Mouse MSC, Rat MSC and Other Types for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Application - Percentage Breakdown of Value Sales for Research Institutes, Hospitals and Other Applications for the Years 2012, 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Type - Percentage Breakdown of Value Sales for Human MSC, Mouse MSC, Rat MSC and Other Types for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Application - Percentage Breakdown of Value Sales for Research Institutes, Hospitals and Other Applications for the Years 2012, 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Mesenchymal Stem Cells (MSC) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Type - Percentage Breakdown of Value Sales for Human MSC, Mouse MSC, Rat MSC and Other Types for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Application - Percentage Breakdown of Value Sales for Research Institutes, Hospitals and Other Applications for the Years 2012, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Type - Percentage Breakdown of Value Sales for Human MSC, Mouse MSC, Rat MSC and Other Types for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Application - Percentage Breakdown of Value Sales for Research Institutes, Hospitals and Other Applications for the Years 2012, 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Type - Percentage Breakdown of Value Sales for Human MSC, Mouse MSC, Rat MSC and Other Types for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Application - Percentage Breakdown of Value Sales for Research Institutes, Hospitals and Other Applications for the Years 2012, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Type - Percentage Breakdown of Value Sales for Human MSC, Mouse MSC, Rat MSC and Other Types for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Application - Percentage Breakdown of Value Sales for Research Institutes, Hospitals and Other Applications for the Years 2012, 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Type - Percentage Breakdown of Value Sales for Human MSC, Mouse MSC, Rat MSC and Other Types for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Application - Percentage Breakdown of Value Sales for Research Institutes, Hospitals and Other Applications for the Years 2012, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Type - Percentage Breakdown of Value Sales for Human MSC, Mouse MSC, Rat MSC and Other Types for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Application - Percentage Breakdown of Value Sales for Research Institutes, Hospitals and Other Applications for the Years 2012, 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Type - Percentage Breakdown of Value Sales for Human MSC, Mouse MSC, Rat MSC and Other Types for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Application - Percentage Breakdown of Value Sales for Research Institutes, Hospitals and Other Applications for the Years 2012, 2020 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Type - Percentage Breakdown of Value Sales for Human MSC, Mouse MSC, Rat MSC and Other Types for the Years 2012, 2020 & 2027 |
| Rest of World Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Application - Percentage Breakdown of Value Sales for Research Institutes, Hospitals and Other Applications for the Years 2012, 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 47 |
Tapping into New Geographical Markets is a Great Way to Grow!
What's Your Addressable Opportunity in the Mesenchymal Stem Cells (MSC) Market?
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com